Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000037

Director acquired 1,358 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dubin Glenn · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-01 Grant or award : show line 1 in the form +1,358 $8.10 $11,000 22,075 D
Loading xslF345X05/wk-form4_1712090040.xml…